Baseline 1 month 3 months 6 months 12 months 24 months Control group Mean (95% CI) % mmol/mol 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) Variance 2.48 2.25 2.25 2.25 2.55 2.25 Intervention group Mean (95% CI) % mmol/mol 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 8.99 (8.75-9.23) 75 (72-77) 9.53(9.11-9.95) 81 (76-85) Variance 2.48 2.25 2.25 2.25 2.55 2.89 Intervention group Covariances (and correlations) Baseline   2.07 (0.88) 1.78 (0.75) 1.82 (0.77) 1.87 (0.74) 1.99 (0.74) 1 month 1.96 (0.83)   1.96 (0.87) 1.96 (0.87) 1.90 (0.79) 1.96 (0.77) 3 months 1.96 (0.83) 1.96 (0.87)   1.96 (0.87) 1.96 (0.82) 1.96 (0.77) Control group 6 months 1.96 (0.83) 1.96 (0.87) 1.96 (0.87)   1.96 (0.82) 1.96 (0.77) 12 months 1.96 (0.78) 1.79 (0.75) 1.96 (0.82) 1.96 (0.82)   1.96 (0.72) 24 months 1.96 (0.83) 1.96 (0.87) 1.96 (0.87) 1.96 (0.87) 1.96 (0.82)

Table 3: Population mean (95%CI), variances and covariances from the model with Hba1c as primary outcome from baseline to 24 months.